A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer
Clinical trial NCT00976989 · COMPLETED
Trial details
- NCT number
- NCT00976989
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-06-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.